Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CXCL10 As a Biomarker Of Interstitial Lung Disease in Patients With Rheumatoid Arthritis

NCT04356066 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04356066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CXCL10 As a Biomarker Of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Unknown status
Start date
December 19, 2020
Completion date
January 19, 2022
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease in patients with rheumatoid arthritis